Prevent HPV Cancers

Cura is dedicated to helping people live healthier lives and the foundation works on initiatives that increase health equity, reduce social disparities and improve the health and well-being of all. Cura aims to eradicate cervical cancer and many head and neck cancers through HPV vaccines.


Every year about 630,000 people worldwide (570,000 women and 60,000 men) are diagnosed with cancers associated with high-risk HPV variants, viruses that cause 6 different types of cancers. The largest portion of HPV-associated cancer cases is attributed to cervical cancer, the 4th leading cause of female cancers in the world (over 604,000 new cases and 341,000 deaths in 2020). Our target is to elevate awareness and campaigns; deliver vaccinations in order to eradicate HPV and significantly reduce related cancers. 

About HPV and Related Cancers

  • High-risk HPV variants are viruses that cause 6 types of cancers including cervical, vaginal, vulvar, anal, penile and oral and throat cancers.

  • Most cervical cancer cases and related deaths occur in Asia (58.2% and 58.5% respectively) and Africa (19.4% and 22.5% respectively).

  • The HPV vaccine can prevent most of these cases and deaths. It is a safe and effective tool that provides long-lasting protection and prevention of HPV-associated cancers. Up to 90% of cervical and anal cancers, 60% to 75% of genital cancers and 70% of oral and throat cancers are preventable by HPV vaccines.

  • The vaccination initiative will aim to improve the knowledge about HPV and the HPV vaccines and provide access to vaccines in areas with lower access.